Frontiers | γδ T Cells for Leukemia Immunotherapy: New and Expanding Trends
Roche - Wikipedia
Ibrutinib - Wikipedia
CLL/SLL: current perspectives across a range of potent agents - memoinOncology
CLL/SLL: current perspectives across a range of potent agents - memoinOncology
Mantle cell lymphoma: refining clinical outcomes beyond the current boundaries - memoinOncology
Frontiers | Therapies for Chronic Allograft Rejection
IMBRUVICA® (ibrutinib) - Cancer Therapy Advisor
List of therapeutic monoclonal antibodies - Wikiwand
Roche - Wikipedia
New Drug Approvals 2013 - Pt. XVIII - Obinutuzumab (Gazyva<sup>TM</sup>)
British Journal of Haematology | Wiley Online Library
non-Hodgkin lymphoma - Wikidata
Obinutuzumab - wikidoc
Optimizing timing, efficacy and tolerability in chronic lymphocytic leukemia - memoinOncology
:quality(90)/ "Roche | Gazyva/Gazyvaro (obinutuzumab)")
Roche | Gazyva/Gazyvaro (obinutuzumab)
FDA accepts Genentech's sBLA for gazyva to treat untreated follicular lymphoma - Pharmaceutical Technology
File:Ibrutinib structure.svg - Wikimedia Commons
CLL/SLL: current perspectives across a range of potent agents - memoinOncology
CD20 - Wikipedia
Combo granted orphan designation for DLBCL | MDedge Hematology and Oncology
Phosphoinositide 3-kinase inhibitor - Wikipedia
Follicular lymphoma: study results with bispecific antibodies and BTK inhibitors - memoinOncology
Ibrutinib - Wikipedia
Obinutuzumab: Uses, Interactions, Mechanism of Action | DrugBank Online
Obinutuzumab - wikidoc
Venetoclax - Wikiwand
